These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10499312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
    Fujimori A, Sakai M, Yoshiya K, Shin J, Kim JI, Inaba Y, Miyamoto T, Inoue S, Fukagawa M.
    Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
    [Abstract] [Full Text] [Related]

  • 4. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
    Delmez JA, Kelber J, Norwood KY, Giles KS, Slatopolsky E.
    Clin Nephrol; 2000 Oct; 54(4):301-8. PubMed ID: 11076106
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism.
    Dressler R, Laut J, Lynn RI, Ginsberg N.
    Clin Nephrol; 1995 May; 43(5):324-31. PubMed ID: 7634548
    [Abstract] [Full Text] [Related]

  • 10. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
    Greenbaum LA, Grenda R, Qiu P, Restaino I, Wojtak A, Paredes A, Benador N, Melnick JZ, Williams LA, Salusky IB.
    Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
    [Abstract] [Full Text] [Related]

  • 11. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism.
    Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK.
    Am J Kidney Dis; 1999 Jan; 33(1):73-81. PubMed ID: 9915270
    [Abstract] [Full Text] [Related]

  • 12. Frequent recurrence of secondary hyperparathyroidism after pulse oral calcitriol withdrawal in PD patients.
    Bajo MA, Selgas R, Possante C, Aguilera A, Sánchez C, Diaz C, de Alvaro F, Martinez ME.
    Adv Perit Dial; 1997 Jan; 13():239-43. PubMed ID: 9360690
    [Abstract] [Full Text] [Related]

  • 13. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H, Koiwa F, Shishido K, Takahashi K, Ito H, Kinugasa E, Taguchi S.
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [Abstract] [Full Text] [Related]

  • 14. [Low dosage intravenous calcitriol bolus therapy in chronic hemodialysis patients].
    Neyer U, Wöss E, Drexel H.
    Acta Med Austriaca; 1994 Jun; 21(5):129-32. PubMed ID: 7709710
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA, Benador N, Goldstein SL, Paredes A, Melnick JZ, Mattingly S, Amdahl M, Williams LA, Salusky IB.
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.
    Maung HM, Elangovan L, Frazão JM, Bower JD, Kelley BJ, Acchiardo SR, Rodriguez HJ, Norris KC, Sigala JF, Rutkowski M, Robertson JA, Goodman WG, Levine BS, Chesney RW, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW.
    Am J Kidney Dis; 2001 Mar; 37(3):532-43. PubMed ID: 11228177
    [Abstract] [Full Text] [Related]

  • 20. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.
    Malberti F, Surian M, Cosci P.
    Kidney Int Suppl; 1993 Jun; 41():S125-30. PubMed ID: 8320905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.